DUBLIN, Dec. 21, 2023 /PRNewswire/ — The “Worldwide Market for In Vitro Diagnostic Tests, 16th Edition” report has been added to ResearchAndMarkets.com’s offering. The 16th edition of The Worldwide Market for In Vitro Diagnostic Tests is based on vendor reporting, interviews, vendor activities, and more on a global scale. This dynamic market is projected to grow over… Continue reading In Vitro Diagnostic Tests Market Report, with Profiles of 300+ Companies and Detail on the Top 40
Category: Newswire
WAINUA™ (eplontersen) granted regulatory approval in the U.S. for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis
U.S. FDA approval based on Phase 3 NEURO-TTRansform results showing WAINUA demonstrated consistent and sustained benefit halting neuropathy disease progression and improving neuropathy impairment and quality of life Additional regulatory reviews for WAINUA underway in rest of world WAINUA will be available in the U.S. in January 2024 CARLSBAD, Calif., Dec. 21, 2023 /PRNewswire/ —… Continue reading WAINUA™ (eplontersen) granted regulatory approval in the U.S. for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis
Animal Transportation Market to increase by USD 600.02 million from 2023 to 2028; A decline in fuel prices increasing profit margins of LSPs to drive the growth – Technavio
NEW YORK, Dec. 21, 2023 /PRNewswire/ — The animal transportation market is expected to grow by USD 600.02 million from 2023 to 2028. However, the growth momentum of the market will be progressing at a CAGR of 5.07% during the forecast period. The market is segmented by Application (Livestock, Pets, and Others), Type (Personal and Commercial), and… Continue reading Animal Transportation Market to increase by USD 600.02 million from 2023 to 2028; A decline in fuel prices increasing profit margins of LSPs to drive the growth – Technavio
FRANDZEL’S HEMAL MASTER RECOGNIZED BY LA BUSINESS JOURNAL AS A 2023 LEADER OF INFLUENCE
LOS ANGELES, Dec. 21, 2023 /PRNewswire/ — Frandzel Robins Bloom & Csato, L.C. announced today that Managing Shareholder Hemal K. Master has been named to the Los Angeles Business Journal’s 2023 Leaders of Influence: Thriving in Their 40s . This yearly accolade highlights prominent professionals in the Los Angeles area who are in their 40s and exhibit continuous success in… Continue reading FRANDZEL’S HEMAL MASTER RECOGNIZED BY LA BUSINESS JOURNAL AS A 2023 LEADER OF INFLUENCE
Packaged Shredded Wheat Cereal Market to increase by USD 46.85 thousand between 2023 to 2028; Increasing internet and e-commerce users drives the market – Technavio
NEW YORK , Dec. 21, 2023 /PRNewswire/ — The packaged shredded wheat cereal market size is expected to grow by USD 46.85 thousand from 2023 to 2028, according to Technavio. In addition, the growth momentum of the market will be progressing at a CAGR of 3.42% during the forecast period. Increasing internet and e-commerce users are notably… Continue reading Packaged Shredded Wheat Cereal Market to increase by USD 46.85 thousand between 2023 to 2028; Increasing internet and e-commerce users drives the market – Technavio
Advanced Orthopedic Technologies, Implants and Regenerative Products Market Report, with Profiles of B. Braun Melsungen AG, Zimmer Biomet, Medtronic, Nuvasive and Stryker
DUBLIN, Dec. 21, 2023 /PRNewswire/ — The “Advanced Orthopedic Technologies, Implants and Regenerative Products” report has been added to ResearchAndMarkets.com’s offering. The global market for advanced orthopedic technologies, implants, and regenerative products was valued at $63.3 billion in 2022. The market is forecast to grow at a compound annual growth rate (CAGR) of 4.1% to reach… Continue reading Advanced Orthopedic Technologies, Implants and Regenerative Products Market Report, with Profiles of B. Braun Melsungen AG, Zimmer Biomet, Medtronic, Nuvasive and Stryker
Structured Finance Market size to grow by USD 997.68 billion from 2023 to 2028; Market is fragmented due to the presence of prominent companies like Avendus Wealth Management Pvt Ltd., Axis Bank Ltd., and Barclays PLC, and many more – Technavio
NEW YORK, Dec. 21, 2023 /PRNewswire/ — The structured finance market is estimated to grow by USD 997.68 billion from 2023 to 2028, growing at a CAGR of 11.8%. The structured finance market is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer structured finance market are Acuity Knowledge… Continue reading Structured Finance Market size to grow by USD 997.68 billion from 2023 to 2028; Market is fragmented due to the presence of prominent companies like Avendus Wealth Management Pvt Ltd., Axis Bank Ltd., and Barclays PLC, and many more – Technavio
Blue Sky Network’s SkyLink Solution Now Supports Iridium Messaging Transport
SCOTTSDALE, Ariz., Dec. 21, 2023 /PRNewswire/ — Blue Sky Network today announced that its dual-mode SkyLink solution now supports the highly-anticipated Iridium Messaging Transport℠ (IMT) service. “We’re proud to offer customers an IMT-integrated SkyLink Messaging Hub, which removes the complexity of using IMT by enabling developers to easily send and receive messages between remote assets… Continue reading Blue Sky Network’s SkyLink Solution Now Supports Iridium Messaging Transport
OMNIA Partners Finalizes Purchase of Value Four, LLC
Transaction Expands Market Presence in Food Service Group Purchasing FRANKLIN, Tenn., Dec. 21, 2023 /PRNewswire/ — Today, OMNIA Partners, the nation’s leading group purchasing organization, completed the acquisition of Value Four, LLC (Value 4) food service group purchasing operations. Value 4 is a leading company dedicated to outsourced purchasing and logistics for the food service… Continue reading OMNIA Partners Finalizes Purchase of Value Four, LLC
Astellas Completes Acquisition of Propella Therapeutics
TOKYO, Dec. 21, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced today that it has completed the acquisition of Propella Therapeutics, Inc. (President and CEO: William Moore, “Propella”), and has become a wholly owned subsidiary of Astellas as of U.S. Eastern Time December 21, 2023. Through the acquisition of… Continue reading Astellas Completes Acquisition of Propella Therapeutics